Use of the VARIPULSE™ Platform marks a significant milestone in the treatment of atrial fibrillation.
Search
Displaying 21 - 40 of 46
The election reinforces the Ottawa Heart Institute’s role as a global leader in combating cardiovascular disease
The Top 25 Canadian Immigrants Awards program celebrates inspirational immigrants who have made a meaningful impact on Canadian society.
Dr. Kelly Cobey is the 2024 recipient of Nature’s John Maddox Prize
Rob deKemp, PhD, MASNC, wins the Abstract of the Year at the 2025 Society of Nuclear Medicine and Molecular Imaging annual meeting in New Orleans
A new trial co-led by the Ottawa Heart Institute and the Research Institute of the McGill University Health Centre shows that continuing these medications offers no added protection against stroke or embolic events compared with low-dose aspirin
The Heart Institute has played a pivotal role toward preventing a serious complication following open-chest surgery by helping launch Rhythm Biotherapeutics Inc.
Heart Institute researchers have completed the first major review of studies looking at how tobacco-free nicotine pouches affect smoking habits
The Acute Cardiac Triage Unit is designed to provide rapid, expert assessment and care for patients with cardiac concerns
Healthcare providers at 16 partner sites will have access to patient health information, enhancing care across the region.
Dr. Rob Beanlands was awarded the Distinguished Teacher/Clinician Award from the American Society of Nuclear Cardiology
The Ottawa Heart Institute Foundation is proud to announce a new partnership with Ottawa Rapid FC, a founding member of the Northern Super League, Canada’s women’s professional soccer league.
New plan prioritizes prevention, timely access, and innovation to address the world’s leading cause of death
Pioneering initiative to be announced Sept. 16
Erin Mulvihill, PhD, is receiving $2M from the Canadian Institute for Health Research for her HEARTWISE project
Dr. Darryl Davis is recognized for his bold creativity and original thinking in cardiovascular research and innovation
Dr. Messika-Zeitoun is an outstanding clinician-investigator who is making an indelible mark for uOttawa, the Heart Institute, and Canada for his novel insights into the pathophysiology and management of Valvular Heart Disease (VHD).
Dr. So’s sustained research and leadership in interventional cardiology have driven exceptional impact in cardiovascular medicine across Canada and internationally.
Dr. Reed is an internationally-recognized expert in the field of cardiovascular prevention and rehabilitation, putting UOHI on the global map as a leader in exercise interventions in cardiovascular disease prevention and rehabilitation.
Dr. Cobey includes patients as valued team members and recognizing the powerful impact of combining science with the lived experience